The strategic deal will also help Goodfellow increase its presence in the rapidly expanding medical device sector and microfluidics.
Goodfellow is a Huntingdon-based supplier of metals, alloys, ceramics, compounds and polymers.
Potomac Photonics also serves as an enabler for numerous promising biomedical applications ranging from cell therapies to cancer diagnostics. It also helps clients develop high-quality miniature components and can micromachine materials such as polymers, metals and glass with feature sizes on the micron-scale that cannot be seen with the naked eye.
The acquisition comes a few months after Goodfellow agreed to a significant distribution contract to launch a new brand and website to boost growth targets.
Simon Kenney, Chief Executive Officer of Goodfellow, commented: “This acquisition ticks all the right boxes for us. Bringing Potomac Photonics into the family allows us to increase our range of products, gives us greater post-processing capabilities and, importantly, delivers a manufacturing plant in the United States."
Mike Adelstein, President and Co-Owner of Potomac Photonics said: “As a business passionate about helping customers solve difficult materials and machining challenges, having access to its global network of clients will enable us to accelerate our reach across key geographies and markets.”
